How does ginsenoside Rk1 modulation of PI3K/Akt pathway lead to increased synaptic protein expression?
OPEN
The study shows Rk1 attenuates Akt upregulation in vitro but increases synaptic proteins in vivo, creating an apparent mechanistic contradiction. The specific downstream signaling events linking PI3K/Akt modulation to enhanced PSD-95 and SYN expression remain unexplained.
Gap type: unexplained_observation
Source paper: Ginsenoside Rk1 alleviates lipopolysaccharide (LPS)-induced cognitive impairment by modulating synaptic plasticity. (2025, Frontiers in pharmacology, PMID:41646936)
Landscape Summary:
How does ginsenoside Rk1 modulation of PI3K/Akt pathway lead to increased synaptic protein expression? is a 0.83 priority gap in synaptic-biology.
It has 0 linked hypotheses with average composite score 0.000.
Status: open.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
How does ginsenoside Rk1 modulation of PI3K/Akt pathway lead to increased synaptic protein expression? — INVOKE-2 (completed)